Consensus Statements on the Clinical Practice for Patients With Fontan‐Associated Liver Disease

Tatsuya Kanto, Teiji Akagi, Hiroyuki Yamagishi, Satoko Ohfuji, Daisuke Tokuhara, Hironori Kusano, Ryotaro Sakamori, Ryosuke Tateishi, Tomomi Kogiso, Tomoharu Yoshizumi, Jun Muneuchi, Norihisa Toh, Ryo Inuzuka, Hideo Ohuchi
Hepatology Research · Wiley · 2026-11-16 · DOI: 10.1111/hepr.70241

Аннотация

ABSTRACT The Fontan procedure has been transformative for patients with univentricular physiology. By using a single ventricle as the systemic pump and relying on passive venous return to drive pulmonary circulation, Fontan circulation alleviates cyanosis and heart failure, allowing children to engage in normal activities during school and adolescence. Nevertheless, Fontan circulation is characterized by chronically elevated systemic venous pressure, which leads to systemic venous congestion and long‐term multiorgan effects. Fontan‐associated liver disease (FALD) is now recognized as a major long‐term complication. Approximately 50% of patients develop hepatic abnormalities within 10–20 years after surgery, and some progress to cirrhosis and hepatocellular carcinoma (HCC). Despite this risk, strategies to identify individuals at high risk for early HCC and to provide better prognostic information remain limited. This article compiles knowledge from congenital heart disease specialists and hepatologists on FALD, including areas where evidence is limited. By facilitating early diagnosis, structured follow‐up, and multidisciplinary management of FALD, this initiative aims to improve outcomes, build a nationwide clinical experience, and ultimately support the development of formal, evidence‐based guidelines for FALD management.

Читать у издателя →

Похожие статьи